Periimplant Mucosa Dynamics Around Divergent and Concave Atlantis Abutment Transition Profiles
Peri-implant Mucosa Dynamics Around Divergent and Concave Atlantis™ Abutment Transition Profiles.
1 other identifier
interventional
61
1 country
1
Brief Summary
The purpose of this study is to compare the effect of two different implant abutment designs on gum tissue volume changes over time after implant placement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 3, 2013
CompletedFirst Posted
Study publicly available on registry
June 6, 2013
CompletedStudy Start
First participant enrolled
December 30, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 3, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 3, 2018
CompletedResults Posted
Study results publicly available
June 14, 2022
CompletedJune 14, 2022
May 1, 2022
4.8 years
June 3, 2013
January 2, 2022
May 19, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Peri-Implant Mucosal Zenith Distance (in Millimeters) at the Concave/Divergent Abutment Sites
Determine if there is a difference in soft tissue peri-implant zenith changes (in millimeters) for the concave/divergent abutment sites, specifically between at delivery and 1, 3, 6, and 12 months after Atlantis Abutment and Restoration Delivery. This measurement is taken using a standardized stereotactic digital photography system that allows for increased measurement accuracy and precision, specifically with the Canfield Dental Camera, Canfield Imaging Systems.
Delivery, and 1, 3, 6, and 12 months after Atlantis Abutment and Restoration Delivery
Secondary Outcomes (2)
Submarginal Buccal-lingual Thickness (Millimeters) in the Peri-implant Transition Zone Relative to a Fixed Reference Point After Prosthesis Delivery
Baseline and 1, 3, 6, and 12 months after Atlantis Abutment and Restoration Delivery
Keratinized Mucosa Width (Millimeters) at the Midfacial Aspect of the Implant Site.
Baseline and 1, 3, 6, and 12 months after Atlantis Abutment and Restoration Delivery
Study Arms (2)
Divergent Abutment
ACTIVE COMPARATORDivergent Transition Profile
Concave Abutment
EXPERIMENTALConcave Transition Profile
Interventions
An Atlantis abutment is delivered with a concave transition profile.
An Atlantis abutment is delivered with a linear transition profile
Eligibility Criteria
You may qualify if:
- years of age or greater
- Subjects requiring replacement of a single-rooted tooth in the maxillary arch from first premolar to first premolar with an implant-supported restoration
- Teeth adjacent (mesial and distal) to study site must consist of two stable, natural teeth without signs of periodontal bone loss (\<2.0mm) and/or significant soft tissue loss
- An opposing dentition with teeth, implants, or fixed prosthesis
- Subjects must be willing to follow instructions related to the study procedures
- Subjects must have read, understood, and signed the informed consent document
You may not qualify if:
- Insufficient interocclusal space for implant placement and/or restoration at study site
- More than 2.0mm vertical bone loss at study site as measured from the mid-buccal crest of the bone on the adjacent teeth
- Untreated rampant caries
- Tobacco use free for ≤ 6 months
- Liver or kidney disfunction/failure
- Active severe infectious diseases that may affect normal healing and/or bone metabolism (e.g. AIDS)
- Uncontrolled diabetes
- Current alcohol or drug abuse
- Need for systemic corticosteroids or any other medication that would influence post-operative healing and/or osseointegration
- History of relevant head/neck cancer and/or radiation of the head/neck
- Subjects who currently use bisphosphonates or have a history of bisphosphonate use
- Subjects with metabolic bone diseases such as osteoporosis or Paget's disease of bone
- Known pregnancy or nursing mothers
- Unable or unwilling to return for follow-up visits for a period of 1 year
- Unlikely to be able to comply with study procedures according to investigators judgement
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Iowa College of Dentistry
Iowa City, Iowa, 52242, United States
Results Point of Contact
- Title
- Dr. Christopher Barwacz
- Organization
- University of Iowa College of Dentistry
Study Officials
- PRINCIPAL INVESTIGATOR
Christopher A Barwacz, DDS
University of Iowa
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 3, 2013
First Posted
June 6, 2013
Study Start
December 30, 2013
Primary Completion
October 3, 2018
Study Completion
October 3, 2018
Last Updated
June 14, 2022
Results First Posted
June 14, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share